NCT00257686

Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients

Study Of Pitavastatin 1 Mg Vs. Pravastatin 10 Mg, Pitavastatin 2 Mg Vs. Pravastatin 20 Mg And Pitavastatin 4 Mg Vs. Pravastatin 40 Mg (Following Up-Titration) In Elderly Patients With Primary Hypercholesterolemia Or Combined Dyslipidemia

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 962 (actual)
• Sponsor: Kowa Research Europe · Industry
• Sex: All
• Age: 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare the efficacy and safety of pitavastatin with that of pravastatin in elderly patients

Detailed description

Following a wash-out dietary lead-in period, patients will receive either Preavastatin or Pitavastatin during 12 weeks, in order to establish the efficacy of pitavastatin in reducing cholesterol levels.

Conditions

• Hypercholesterolemia or Combined Dyslipidemia

Interventions

Type	Name	Description
DRUG	Pitavastatin
DRUG	Pravastatin

Timeline

• Start date: 2005-09-01
• Primary completion: 2006-05-01
• Completion: 2006-05-01
• First posted: 2005-11-23
• Last updated: 2010-03-16
• Results posted: 2010-01-18

Locations

62 sites across 5 countries: Denmark, Germany, Israel, Netherlands, United Kingdom